Structural definition of a conserved neutralization epitope on HIV-1 gp120

被引:629
作者
Zhou, Tongqing
Xu, Ling
Dey, Barna
Hessell, Ann J.
Van Ryk, Donald
Xiang, Shi-Hua
Yang, Xinzhen
Zhang, Mei-Yun
Zwick, Michael B.
Arthos, James
Burton, Dennis R.
Dimitrov, Dimiter S.
Sodroski, Joseph
Wyatt, Richard
Nabel, Gary J.
Kwong, Peter D.
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA
[3] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[4] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[5] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[6] Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA
[7] NCI, Ctr Canc Res, Frederick, MD 21702 USA
关键词
D O I
10.1038/nature05580
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The remarkable diversity, glycosylation and conformational flexibility of the human immunodeficiency virus type 1 (HIV-1) envelope (Env), including substantial rearrangement of the gp120 glycoprotein upon binding the CD4 receptor, allow it to evade antibody-mediated neutralization. Despite this complexity, the HIV-1 Env must retain conserved determinants that mediate CD4 binding. To evaluate how these determinants might provide opportunities for antibody recognition, we created variants of gp120 stabilized in the CD4-bound state, assessed binding of CD4 and of receptor-binding-site antibodies, and determined the structure at 2.3 angstrom resolution of the broadly neutralizing antibody b12 in complex with gp120. b12 binds to a conformationally invariant surface that overlaps a distinct subset of the CD4-binding site. This surface is involved in the metastable attachment of CD4, before the gp120 rearrangement required for stable engagement. A site of vulnerability, related to a functional requirement for efficient association with CD4, can therefore be targeted by antibody to neutralize HIV-1.
引用
收藏
页码:732 / 737
页数:6
相关论文
共 50 条
[1]   Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein - Implications for therapeutic and vaccine strategies [J].
Arthos, J ;
Cicala, C ;
Steenbeke, TD ;
Chun, TW ;
Cruz, CD ;
Hanback, DB ;
Khazanie, P ;
Nam, D ;
Schuck, P ;
Selig, SM ;
Van Ryk, D ;
Chaikin, MA ;
Fauci, AS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :11456-11464
[2]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[3]   A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates [J].
Barouch, DH ;
Yang, ZY ;
Kong, WP ;
Korioth-Schmitz, B ;
Sumida, SM ;
Truitt, DM ;
Kishko, MG ;
Arthur, JC ;
Miura, A ;
Mascola, JR ;
Letvin, NL ;
Nabel, GJ .
JOURNAL OF VIROLOGY, 2005, 79 (14) :8828-8834
[4]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[5]   EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY [J].
BURTON, DR ;
PYATI, J ;
KODURI, R ;
SHARP, SJ ;
THORNTON, GB ;
PARREN, PWHI ;
SAWYER, LSW ;
HENDRY, RM ;
DUNLOP, N ;
NARA, PL ;
LAMACCHIA, M ;
GARRATTY, E ;
STIEHM, ER ;
BRYSON, YJ ;
CAO, YZ ;
MOORE, JP ;
HO, DD ;
BARBAS, CF .
SCIENCE, 1994, 266 (5187) :1024-1027
[6]   Antibodies, viruses and vaccines [J].
Burton, DR .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (09) :706-713
[7]  
BURTON DR, 1997, AIDS SA, V11, P587
[8]   Effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in Chinese hamster ovary cells:: Application to glycoprotein crystallization [J].
Butters, TD ;
Sparks, LM ;
Harlos, K ;
Ikemizu, S ;
Stuart, DI ;
Jones, EY ;
Davis, SJ .
PROTEIN SCIENCE, 1999, 8 (08) :1696-1701
[9]   Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[10]   Structure of an unliganded simian immunodeficiency virus gp120 core [J].
Chen, B ;
Vogan, EM ;
Gong, HY ;
Skehel, JJ ;
Wiley, DC ;
Harrison, SC .
NATURE, 2005, 433 (7028) :834-841